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Objective: Physical pain and negative affect have been described as risk factors for alcohol use following
alcohol treatment. The current study was a secondary analysis of 2 clinical trials for alcohol use disorder
(AUD) to examine the associations between pain, negative affect and AUD treatment outcomes. Method:
Participants included 1,383 individuals from the COMBINE Study (COMBINE Study Research Group, 2003;
31% female, 23% ethnic minorities, average age  44.4 [SD  10.2]), a multisite combination pharmaco-
therapy and behavioral intervention study for AUD in the United States, and 742 individuals from the United
Kingdom Alcohol Treatment Trial (UKATT Research Team, 2001; 25.9% female, 4.4% ethnic minorities,
average age  41.6 [SD  10.1]) a multisite behavioral intervention study for AUD in the United Kingdom.
The Form-90 was used to collect alcohol use data, the Short Form Health Survey and Quality of Life measures
were used to assess pain, and negative affect was assessed using the Brief Symptom Inventory (COMBINE)
and the General Health Questionnaire (UKATT). Results: Pain scores were significantly associated with
drinking outcomes in both datasets. Greater pain scores were associated with greater negative affect and
increases in pain were associated with increases in negative affect. Negative affect significantly mediated the
association between pain and drinking outcomes and this effect was moderated by social behavior network
therapy (SBNT) in the UKATT study, with SBNT attenuating the association between pain and drinking.
Conclusion: Findings suggest pain and negative affect are associated among individuals in AUD treatment
and that negative affect mediated pain may be a risk factor for alcohol relapse.
What is the public health significance of this article?
This study highlights the important associations between physical pain interference and intensity,
negative affect, and alcohol use following treatment for an alcohol use disorder. Social network
behavior therapy, which is one type of behavioral intervention for alcohol use disorders, may be
particularly useful for preventing alcohol use in response to physical pain and negative affect.
Keywords: alcohol use disorder (AUD) treatment, pain interference, pain intensity, negative affect,
alcohol relapse
Alcohol relapse, defined as the process of returning to heavy
drinking (often defined as 4/5 drinks per occasion for women/
men) after a period of abstinence or reduced alcohol use, is
common in those with a history of alcohol use disorder (AUD), a
diagnosis often associated with periods of heavy drinking and
consequent negative impacts of drinking on functioning (Leshner,
1997; Sutton, 1979). The accurate identification of factors that
increase the risk of relapse is of crucial importance and there have
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been widespread efforts to identify the relevant risk factors in
order to improve relapse prevention interventions (Connors,
Maisto, & Donovan, 1996; Moos & Moos, 2006; Witkiewitz &
Marlatt, 2004).
Nearly all models of the relapse process have proposed an
interaction between biological, psychological, environmental, and
social factors, with an emphasis on more stable risk factors (i.e.,
distal or tonic risk; Shiffman, 1989; Witkiewitz & Marlatt, 2004)
creating heightened vulnerability for relapse in the presence of
more immediate risk factors (i.e., proximal or phasic risk; Shiff-
man, 1989; Witkiewitz & Marlatt, 2004). For example, a recent
analysis by Chow, Witkiewitz, Grasman, Hutton, and Maisto
(2013) found that individuals who were high in distal risk were
significantly more likely to experience a lapse if proximal risk
(characterized by negative emotions, perceived stress, and craving)
was heightened within the first 2 weeks of treatment. Similar
studies of proximal risks such as dependence severity, emotional
distress, and social support and recovery resources provide further
support for proximal risks’ potential role in increasing or decreas-
ing the probability of relapse to problematic alcohol use (e.g.,
Garland, Franken, & Howard, 2012; Moos & Moos, 2006; Wit-
kiewitz & Villarroel, 2009; Witkiewitz, 2011). Despite the iden-
tification of multiple risk factors, very few studies—and few
theoretical models—have acknowledged the common experience
of physical pain and pain interference as potential predictors of
alcohol treatment outcomes (Booker, Haig, Geisser, & Yamakawa,
2003; Witkiewitz et al., 2015). This gap in the literature is sur-
prising given evidence supporting the relationship between pain
and negative affect (e.g., Davis, Zautra, & Smith, 2004), as well as
the association between negative affect and alcohol use (Witkie-
witz & Villarroel, 2009). Furthermore, alcohol has historically
been used for its analgesic affect (Trafton, Oliva, Horst, Minkel, &
Humphreys, 2004; Woodrow & Eltherington, 1988), and individ-
uals with AUD have identified pain as both a common experience
and as a primary reason for alcohol use (Caldeiro et al., 2008).
Given these findings, it is plausible that an important association
may be present between the experience of pain and AUD treatment
outcomes (Witkiewitz et al., 2015). The relation between pain and
AUD treatment outcomes may also be explained by experiences of
negative affect.
Exploring this possibility was the primary objective of the
present analyses. Specifically, the association between pain, neg-
ative affect, and alcohol treatment outcomes was examined via
secondary analyses of data from two randomized clinical trials for
alcohol dependence: the COMBINE Study (COMBINE Study
Research Group, 2003), a large multisite randomized clinical trial
for alcohol dependence conducted in the United States, and the
United Kingdom Alcohol Treatment Trial (UKATT Research
Team, 2001), a large randomized clinical trial for alcohol problems
conducted in the United Kingdom (U.K.). It was hypothesized that
pain would be associated with alcohol treatment outcomes (Hy-
pothesis 1) and negative affect (Hypothesis 2) and that negative
affect would mediate the association between pain and drinking
outcomes (Hypothesis 3). Additional exploratory analyses were
conducted to determine whether the treatments received in the
COMBINE or UKATT studies had any influence on pain, as well
as whether treatment moderated any of the associations between
pain, negative affect, and alcohol treatment outcomes.
Method
COMBINE Participants and Procedures
The COMBINE study (Combined Pharmacotherapies and Be-
havioral Interventions for Alcohol Dependence; COMBINE Study
Research Group, 2003) randomized 1,383 subjects across 11 re-
search sites into nine treatment groups, consisting of a combination
of medical management (MM) or combined behavioral interven-
tion (CBI) and medications (acamprosate, naltrexone, or placebo
versions of each drug). Subjects received treatment for a total of 4
months; participants were offered nine MM visits and a maximum
of 20 CBI sessions. Participants completed assessments at 2.5
months, 9 months, and 12 months following treatment.
The sample was recruited from treatment referrals at the study
sites and throughout the community, as described previously (An-
ton et al., 2006). Individuals were excluded from participation if
they were dependent on another drug besides alcohol, nicotine, or
cannabis, had recently used opioids, had a serious mental illness,
or any other medical condition that could disrupt study participa-
tion, had taken one of the study medications 30 days prior to
baseline, or took medication that could raise the potential risks of
the study. Inclusion criteria required participants have a minimum
of 14 drinks (females) or 21 drinks (males) on average per week
over a successive 30 days in the 90-day period prior to beginning
abstinence, having 2 or more days of heavy drinking (defined as
4 drinks for females and 5 drinks for males) in the 90-day
period with the last drink being within 21 days of enrollment.
Of the 1,383 participants in COMBINE, 31% were female and
69% were male, 23% of the study patients were ethnic minorities
(76.3% non-Hispanic White, 11.6% Hispanic American, 7.8%
African American, and 4.1% “other”). The participants’ mean age
was 44.4 years (SD  10.2), 71% had at least 12 years of
education, and 42% were married.
UKATT Participants and Procedures
For UKATT (UKATT Research Team, 2001), 742 subjects
across seven treatment sites in Birmingham, Cardiff, and Leeds
were randomized into two treatment groups: either motivation
enhancement therapy (MET) or social behavior and network ther-
apy (SBNT; UKATT Research Team, 2005). Subjects received
treatment for a total of 2 to 3 months; participants receiving SBNT
received up to eight sessions and those who received MET re-
ceived up to three sessions. Participants completed assessments at
3 and 12 months after entry into the trial.
Participants were recruited into the study if they were seeking
alcohol treatment from one of the treatment sites (UKATT Re-
search Team, 2001, 2005). Individuals were excluded from par-
ticipation if abuse or dependence of other drugs besides alcohol
was a more serious problem, had uncontrolled psychotic symptoms
or severe cognitive impairment, could not name a contact person,
were planning to leave the area, were under 16 years old, or were
illiterate.
Of the 742 participants in UKATT, 25.9% were female and
74.1% were male, 95.6% of the participants were White and 4.4%
of the study patients were ethnic minorities (1.2% Black, 2.0%
Indian or other Asian, 0.1 Pakistani, and 0.9% “other”). The mean
age was 41.6 years (SD  10.1), 10% had a secondary degree or
equivalent training, and 44% were married.
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Measures
Alcohol use. In both COMBINE and UKATT, alcohol con-
sumption was assessed using a calendar method via the Form-90
Interview (Miller, 1996). In COMBINE daily alcohol consump-
tion, measured in U.S. standard drink units (unit of alcohol 
11.358 g), was assessed for 485 days (120 days during treatment
and 365 days following treatment). In UKATT daily alcohol
consumption, measured in U.K. standard drink units (unit of alco-
hol  8 g of ethanol), was assessed for the prior 90 days at
baseline, 3-month follow-up (corresponding to the posttreatment
assessment), and the 12-month follow-up. Four outcome variables
were derived from the Form-90 data in each of the studies: percent
drinking days (PDD; a measure of drinking frequency), drinks per
drinking day (DDD; a measure of drinking intensity), percent
heavy drinking days (PHDD; defined as percentage of days with
4/5 drinks for women/men), and the maximum number of
drinks on the peak drinking occasion (MXD, a measure of peak
drinking).
Pain. In COMBINE, pain was assessed via two items. One
item was from the 26-item World Health Quality of Life (WHO-
QOL) assessment (World Health Organization, 1998): “To what
extent do you feel that physical pain prevents you from doing what
you need to do?” with response options ranging from 1 not at all
to 5 an extreme amount. The second item was from the 12-item
Short Form Health Survey (SF-12; Ware, Kosinski, & Keller,
1996): “During the past 4 weeks, how much did pain interfere with
your normal work including both work outside the home and
housework?” with response options ranging from 1 not at all to 5
extremely. The WHO-QOL measure was administered at baseline,
6.5 months postbaseline, and 12 months postbaseline. The SF-12
was administered at baseline, 4 months postbaseline, and 12
months postbaseline. For both items we found that the greatest
pain interference categories of an extreme amount (WHO-QOL)
and extremely (SF-12) had very low response rates (less than 1%
indicated this level of pain interference). To address this, we
recoded the response options for the WHO-QOL to be from 1 not
at all to 4 very much or an extreme amount and the response
options for the SF-12 to be from 1 not at all to 4 quite a bit or
extremely. Internal consistency reliability of the two items ex-
ceeded   .81 at all assessment time points.
In UKATT, pain was assessed via three items including one
item from the European Quality of Life Group EQ-5D (European
Quality of Life Group, 1990), a general measure of health status on
five dimensions, and two items from the 36-item Short Form
Health Survey (SF-36, Ruta, Garratt, Abdalla, Buckingham, &
Russell, 1993). One item, the same item that was included in the
SF-12 from COMBINE, measured pain interference: “During the
past 4 weeks, how much did pain interfere with your normal work
including both work outside the home and housework?” with
response options ranging from not at all to extremely. Two items
assessed pain intensity, one from the EQ-5D: “Please indicate
which statement best describes your health today” with response
options of I have no pain or discomfort, I have moderate pain or
discomfort, or I have extreme pain or discomfort and one from the
SF-36: “How much bodily pain have you had during the past 4
weeks” with response options ranging from none to very severe.
The EQ-5D and SF-36 were administered at baseline, 3 months,
and 12-month follow-ups. Internal consistency reliability of the
three items was   .77 at baseline and exceeded   .81 at 3- and
12-month time points.
Negative affect. In COMBINE, negative affect was measured
by the Depression and Anxiety domains of the 53-item Brief
Symptom Inventory (BSI; Derogatis & Melisaratos, 1983), which
assesses self-reported psychiatric symptomatology across nine do-
mains via ratings on a 5-point scale (0  not at all, 4  extremely).
The BSI was administered at baseline as well as postbaseline
months 4 (end of treatment), 6.5 (2.5 months posttreatment, 12 (9
months posttreatment) and 16 (12 months posttreatment). Scores
on the Depression and Anxiety domains were used as indicators of
a negative affect latent variable at each time point. Internal con-
sistency reliability of the BSI exceeded   .97 at all assessment
time points.
In UKATT, negative affect was measured by the Depression and
Anxiety/Insomnia domains of the 28 item General Health Ques-
tionnaire (GHQ-28; Goldberg, 1972), which is a measure of psy-
chiatric disturbance in four domains: Somatic Symptoms, Anxiety/
Insomnia, Social Dysfunction, and Depression. The GHQ was
administered at baseline, 3 months, and 12-month follow-ups.
Scores on the Anxiety/Insomnia and Depression domains were
used as indicators of a negative affect latent variable assessed at
baseline, 3 months (posttreatment), and 12-month follow-up. In-
ternal consistency reliability of the GHQ exceeded   .96 at all
assessments time points.
Covariates. Acknowledging that other factors are often asso-
ciated with pain, negative affect, and alcohol treatment outcomes;
we included a number of covariates in the final mediation models.
Covariates were not included in the models of associations be-
tween pain and drinking outcomes or in the models of associations
between pain and negative affect because we were primarily
interested in the bivariate associations among these constructs,
without the additional influence of covariates. Covariates in both
the COMBINE and UKATT studies included: demographic vari-
ables (gender, marital status, employment, income, and minority
status), baseline dependence severity [assessed via the Alcohol
Dependence Scale (ADS; Skinner & Horn, 1984) in COMBINE
and the Leeds Dependence Questionnaire (LDQ; Raistrick et al.,
1994) in UKATT], number of alcohol dependence symptoms
based on the Diagnostic and Statistical Manual for Mental Disor-
ders—4th Edition Text Revision (DSM–IV–TR; American Psychi-
atric Association, 1995), readiness to change [assessed using the
University of Rhode Island Change Assessment scale (URICA;
DiClemente & Hughes, 1990) in COMBINE and the Readiness to
Change Questionnaire–Treatment Version (RTCQ; Heather &
Honekopp, 2008) in UKATT], and self-efficacy was assessed
using the Alcohol Abstinence Self-Efficacy Scale (AASE; DiCle-
mente, Carbonari, Montgomery, & Hughes, 1994). In UKATT,
which did not exclude opiate users (n  67, 9.0% of the UKATT
sample), we included opiate use as a covariate.
Statistical Analyses
Analyses were conducted to test the three hypotheses listed
above regarding the association between pain, negative affect, and
alcohol treatment outcomes. Models were estimated in the
COMBINE and UKATT datasets using Mplus version 7.2
(Muthén & Muthén, 2012) with maximum likelihood estimation,
which is a preferred method for estimation when some data are
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missing (Schafer & Graham, 2002). These models were considered
to provide a reasonable fit to the data with a Root Mean Square Error
of Approximation (RMSEA; Browne & Cudeck, 1993) 0.08 and
the Comparative Fit Index (CFI; Bentler, 1990) 0.90. There are
varying opinions on the best cut-offs for the RMSEA and CFI for
evaluating model fit, with some arguing for RMSEA 0.06 and
CFI 0.95 as indicative of good fit (Hu & Bentler, 1999). We
believed it was important not to focus exclusively on fit indices
(although model fit is important) and to consider the replication of
models across two samples as the ultimate goal.
Measurement models of pain and negative affect. First, we
created longitudinal measurement models of the pain and negative
affect constructs within each dataset. The underlying measurement
model for each construct was selected based on the distributions of
the data available, with graded response models used for ordered
categorical items and confirmatory factor analysis used for con-
tinuous scale scores.
For the pain items, which were ordered categorical, we used
longitudinal graded response models (Samejima, 1969, 1997) to
create individual graded response scores at each time point using
the expected a posteriori approach. Separate graded response mod-
els were estimated in the COMBINE and UKATT studies in order
to generate graded response scores (similar to factor scores) for the
pain latent factors at each time point (COMBINE: baseline, 4-,
6.5-, and 12 months postbaseline; UKATT: baseline, 3-, and 12
months postbaseline).
For negative affect variables, which were continuous scale
scores, we used longitudinal confirmatory factor analyses (Little,
Preacher, Selig, & Card, 2007; Little, 2013) to create study-
independent latent factor scores at each time point. Longitudinal
confirmatory factor analysis is a repeated measures extension of
the confirmatory factor analysis model, whereby factor loadings
and item intercepts are constrained to equality across time. First,
we estimated latent factor models of negative affect at each time
point (COMBINE: baseline, and 4-, 6.5-, 12-, and 16 months
postbaseline; UKATT: baseline and 3-, and 12 months postbase-
line) and then combined them into a longitudinal model with
constraints placed on the item loadings, intercepts, and variance-
covariance matrix to test for measurement invariance of the latent
factor across time (Byrne, Shavelson, & Muthén, 1989). Models
were estimated separately in the COMBINE and UKATT studies
in order to generate factor scores for the negative affect latent
factors at each time point.
For each dataset we used the pain graded response scores and
negative affect latent factor scores as indicators in latent growth
curve models of changes in pain and negative affect, respectively,
over time. Parameters derived from a latent growth model provide
information about a construct’s average level (mean intercept) and
average change over time (mean slope), as well as the individual
variance around the intercept and slope. A significant intercept
would indicate an average level that is significantly different from
zero, whereas a significant slope would indicate an increase or
decrease in either pain or negative affect score that was signifi-
cantly different from no change. In both datasets we set the
intercept for the growth models at the end of treatment
(COMBINE: 4-month assessment; UKATT: 3-month assessment)
and we examined the fit of models using varying parameterizations
of the growth process (linear, quadratic, nonlinear). Linear growth
represents the average rate of change in pain and negative affect
scores over time, quadratic growth represents acceleration or de-
celeration in the rate of change (e.g., the change is more rapid or
slowed, introducing a parabolic change pattern), and nonlinear
growth models could be used to identify other functional forms of
growth (e.g., exponential growth).
Hypothesis 1: Association between pain and alcohol treat-
ment outcomes. The association between pain and alcohol treat-
ment outcomes was assessed by extending the latent growth model
of pain to predict 12-month alcohol treatment outcomes. Specifi-
cally, we tested the association between the intercept and slope
parameters of the pain latent growth curve models and 12-month
drinking outcomes (PDD, DDD, PHDD, MXD), while controlling
for baseline levels of the outcomes. For COMBINE the 12-month
outcomes represented outcomes 1 year following treatment (16
months following baseline assessment), whereas for UKATT the
12-month outcome represented drinking outcomes 9 months fol-
lowing completion of treatment (12 months following baseline
assessment).
Hypothesis 2: Association between pain and negative affect.
The association between pain and negative affect scores over time
was assessed using parallel process latent growth models. In
COMBINE, we examined changes in negative latent factors across
months 4 (intercept), 6.5, 12, and 16 as associated with changes in
pain graded response scores across months 4 (intercept), 6.5, and
12. In UKATT we examined changes in negative latent factors
across baseline to Month 3 (intercept) to Month 12 as associated
with changes in pain graded response scores across baseline to
Month 3 (intercept) to Month 12. In both the COMBINE and
UKATT datasets we covaried the growth parameters (i.e., intercept
parameters and slope parameters) across the pain and negative
affect growth processes.
Hypothesis 3: Pain and alcohol treatment outcomes medi-
ated by negative affect. Next, we extended the parallel process
growth models of pain and negative affect to include covariates
and the 12-month drinking indices as outcomes of the pain and
negative affect latent growth parameters, with the negative affect
growth process tested as mediating the effect of the pain growth
process on 12-month drinking outcomes, as shown in Figure 1a
(COMBINE) and b (UKATT). Mediation models were estimated
using the product of coefficients approach (MacKinnon, Lock-
wood, Hoffman, West, & Sheets, 2002), which provides an esti-
mate of the mediated effect by multiplying two regression coeffi-
cients: (a) the regression of the mediator on the independent
variable (the “a-path”), and (b) the regression of the outcome on
the mediator (the “b-path”), with the independent variable included
in the model (MacKinnon, 2008). The mediation models tested in
the current paper examined negative affect growth (the mediator)
regressed on pain growth (the independent variable), and the
drinking outcomes (outcome) regressed on negative affect growth,
with the inclusion of pain growth in the model. The 95% confi-
dence intervals for the mediated effects were estimated using
bootstrapping with 1,000 bootstrap samples.
Exploratory analyses: Effects of treatment assignment. In
the final set of analyses we examined two questions regarding the
effects of treatment on pain, negative affect, and alcohol treatment
outcomes. First, we examined whether randomly assigned treat-
ment condition in COMBINE (naltrexone, acamprosate, or pla-
cebo in combination with MM or CBI) or UKATT (MET or
SBNT) significantly predicted pain scores by including fixed ef-
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fects of treatment in the pain latent growth curve models. Second,
we examined whether treatment condition moderated the associa-
tion between pain, negative affect, and alcohol treatment outcomes
by including moderating effects of treatment (i.e., an interaction
term for centered pain scores by treatment condition) in each set of
analyses described above. For both studies we created dummy-
coded variables for treatment effects. In COMBINE we examined
three contrasts: naltrexone (coded 1) versus no naltrexone (coded
0); acamprosate (coded 1) versus no acamprosate (coded 0); and
CBI (coded 1) versus MM  CBI (coded 0). In UKATT, we
examined one contrast: SBNT (coded 1) versus MET (coded 0).
Results
Descriptive Statistics
Means (standard deviations) of all continuous measures (e.g.,
BSI, GHQ, Form 90 drinking outcomes) and the frequency (%) of
item responses on the WHO-QOL and SF-12 items (COMBINE
study) and EQ-5D and SF-36 items (UKATT study) are provided
in Tables 1 (COMBINE) and 2 (UKATT). In both studies, we
observed reductions in pain (defined as interference in COMBINE
and both pain interference and pain intensity in UKATT), depres-
Figure 1. a. Parallel process growth mediation model in COMBINE. BSI  Brief Symptom Inventory;
WHO-QOL  World Health Organization Quality of Life measure of pain interference; SF-12  Short Form
12 measure of pain interference. b. Parallel process growth mediation model in UKATT. GHQ  General
Health Questionnaire; EQ-5D  European Quality of Life measure of pain intensity; SF-36  Short Form 36
Health Survey measure of pain intensity and pain interference.Th
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sion and anxiety scores, and drinking frequency and intensity from
baseline to the follow-up assessments.
Measurement and Latent Growth Models of Pain and
Negative Affect
Pain graded response model. The longitudinal graded re-
sponse models of pain provided an adequate fit to the observed
data in the COMBINE data (2(13)  70.04, RMSEA  0.06
(90% CI: 0.044, 0.070), CFI  0.99) and the longitudinal
graded response model of pain provided a reasonable fit to the
observed data in UKATT (2(43)  279.97, RMSEA  0.08
(90% CI: 0.077, 0.096), CFI  0.99). Means (standard devia-
tions) for model-generated pain scores are provided in Tables 1
and 2.
Negative affect factor model. The longitudinal confirmatory
factor analyses of the negative affect scales also provided an
Table 1
Descriptive Statistics, N (%) or Mean (Standard Deviation), for COMBINE Study Variables
Baseline 4 months 6.5 months 12 months 16 months
WHO-QOL pain interference
1-Not at all 845 (62%) — 705 (66%) 608 (64%) —
2-A little 335 (25%) — 221 (21%) 220 (23%) —
3-A moderate amount 120 (9%) — 95 (9%) 90 (9%) —
4-Very much/extremely 51 (4%) — 40 (4%) 37 (4%) —
SF-12 pain interference
1-Not at all 796 (59%) 762 (69%) — 577 (61%) —
2-A little bit 342 (25%) 237 (22%) — 234 (24%) —
3-Moderately 137 (10%) 70 (6%) — 93 (10%) —
4-Quite a bit/extremely 81 (6%) 33 (3%) — 47 (5%) —
BSI–Depression (range 42–80) 61.6 (10.6) 55.1 (10.6) 55.5 (11.3) 55.3 (11.0) 55.2 (11.1)
BSI–Anxiety (range 38–80) 58.4 (11.5) 51.3 (11.1) 51.5 (11.7) 50.9 (11.1) 51.1 (11.4)
Percent drinking days 78.6 (22.5) 27.3 (33.5) 36.2 (37.8) 38.0 (38.7) 37.4 (39.1)
Drinks per drinking day 12.9 (8.1) 4.7 (5.8) 5.6 (6.7) 5.4 (6.4) 5.3 (6.3)
Percent heavy drinking days 73.7 (24.7) 19.8 (29.9) 27.7 (35.3) 29.4 (36.7) 29.3 (37.3)
Maximum drinks per day 22.2 (14.0) 6.7 (8.3) 7.3 (8.5) 7.1 (8.1) 5.9 (8.1)
Pain scores (range 0.5–2.5) 0.13 (0.73) 0.11 (0.64) 0.13 (0.77) 0.15 (0.70) —
Affect scores (range 2.7–2.5) 0.01 (0.94) 0.01 (0.89) 0.00 (0.92) 0.01 (0.95) 0.01 (0.95)
Note. WHO-QOL  World Health Organization Quality of Life survey; SF-12  Short Form Health Survey; BSI  Brief Symptom Inventory.
Table 2
Descriptive Statistics, N (%) or Mean (Standard Deviation), for UKATT Study Variables
Baseline 3 months 12 months
EQ-5D pain intensity
1-No pain or discomfort 265 (36%) 284 (44%) 227 (40%)
2-Some pain or discomfort 419 (57%) 332 (51%) 293 (52%)
3-Extreme pain or discomfort 47 (7%) 34 (5%) 43 (8%)
SF-36 pain interference
1-Not at all 207 (28%) 273 (42%) 194 (35%)
2-A little bit 178 (24%) 150 (23%) 129 (23%0
3-Moderately 152 (21%) 92 (14%) 91 (16%)
4-Quite a bit 122 (17%) 93 (15%) 93 (17%)
5-Extremely 72 (10%) 39 (6%) 54 (10%)
SF-36 pain intensity
1-None 109 (14.9%) 169 (26%) 137 (24%)
2-Very mild 95 (13.0%) 105 (16%) 83 (15%)
3-Mild 133 (18.2%) 102 (16%) 96 (17%)
4-Moderate 241 (32.9%) 174 (27%) 132 (23%)
5-Severe 110 (15.0%) 74 (11%) 78 (14%)
6-Very severe 44 (6.0%) 24 (4%) 38 (7%)
GHQ—Depression (range 0–21) 7.92 (6.20) 5.61 (6.02) 5.24 (6.10)
GHQ—Anxiety (range 0–21) 10.97 (5.38) 8.37 (5.57) 7.96 (5.85)
Percent drinking days 78.1 (24.96) 50.36 (38.3) 49.59 (39.6)
Drinks per drinking day 24.64 (14.73) 14.40 (13.26) 13.70 (13.43)
Percent heavy drinking days 76.51 (25.95) 46.78 (38.56) 45.44 (39.91)
Maximum drinks per day 35.28 (19.76) 20.08 (17.89) 18.95 (18.39)
Pain scores (range 1.49–2.49) 0.06 (0.81) 0.05 (0.82) 0.0004 (.82)
Affect scores (range 1.74–2.79) 0.001 (0.90) 0.01 (0.90) 0.01 (0.89)
Note. EQ-5D  European Quality of Life survey; SF-36  Short Form Health Survey; GHQ  General Health
Questionnaire.
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adequate fit to the observed data in COMBINE (2(25)  53.41,
RMSEA  0.03 (90% CI: 0.019, 0.041), CFI  0.996) and a
reasonable fit to the observed data in UKATT (2(24)  69.90,
RMSEA  0.05 (90% CI: 0.037, 0.065), CFI  0.99). All factor
loadings exceeded 0.80 in both studies. Finally, in both studies, the
longitudinal confirmatory factor models were found to display
strong invariance across time (item loadings and item intercepts
constrained to equality). From these models we generated negative
affect scores using the modal posterior estimator approach. De-
scriptive statistics for the negative affect scores are provided in
Tables 1 (COMBINE) and 2 (UKATT).
Pain and negative affect latent growth models. The pain
graded response scores and negative affect scores at each time
point were then entered into separate latent growth curve models.
For COMBINE, the final pain model with the intercept at Month
4 and linear slope provided an excellent fit to the data (2(2) 
11.23, RMSEA  0.06 (90% CI: 0.028, 0.093), CFI  0.99) and
the final negative affect model with the intercept at Month 4 and
both linear and quadratic slopes provided an excellent fit to the
data (2(3)  3.09, RMSEA  0.005 (90% CI: 0.000, 0.048),
CFI  1.00). For the UKATT data, the final pain model and the
final negative affect model included the intercept centered at the
3-month follow-up (end of treatment) with linear and quadratic
slopes. Both models were just-identified (e.g., the model degrees
of freedom equal zero) with a random linear slope and fixed
quadratic slope (2(0)  0.00, RMSEA  0.00), CFI  1.00).
Hypotheses 1: Pain and Alcohol Treatment Outcomes
In order to test the association between pain and drinking
outcomes, we examined the association between the intercept and
slope parameters from the pain latent growth models and the
12-month drinking outcomes (PDD, DDD, PHDD, and MXD),
while also controlling for baseline levels of the outcomes. All
models provided an acceptable fit to the observed data. As shown
in Table 3, results indicated that the end-of-treatment pain scores
(intercepts in the latent growth models) were significantly associ-
ated with all four drinking outcomes in both COMBINE and
UKATT. Thus, Hypothesis 1 was supported given that pain was
significantly associated with drinking outcomes. Change in pain
scores over time (slope) did not significantly predict 12-month
outcomes, above and beyond the intercept and baseline levels of
the outcomes. Across all models, including baseline drinking as a
predictor, 5–10% of the variance in 12-month drinking outcomes
was explained by the model. With baseline drinking excluded from
the model (results not shown), pain independently explained 1–5%
of the variance in drinking outcomes.
Hypothesis 2: Association Between Pain and Negative
Affect
The parallel process growth models of pain and negative affect
scores provided a reasonable fit to the data for COMBINE
(2(14)  120.08, RMSEA  0.07 (90% CI: 0.062, 0.087), CFI 
0.989) and a slightly less than adequate fit based on RMSEA in the
UKATT dataset (2(6)  63.10, RMSEA  0.11 (90% CI: 0.08,
0.14), CFI  0.98). In both datasets the associations between the
growth processes of pain and negative affect were significant,
such that the intercepts were significantly positively associated
(COMBINE: B (SE)  0.19 (0.02), p  .001; UKATT: B (SE) 
0.28 (0.02), p  .001) and the slopes were positively associated
(COMBINE: B (SE)  0.001 (0.00), p  .001; UKATT: B (SE) 
0.05 (0.01), p  .001). Thus a higher level of pain was associated
with a higher level of negative affect (intercept) and increases in
pain were associated with increases in negative affect (slope),
providing support for Hypothesis 2. In both datasets, the intercept
of pain was not significantly associated with the slope of negative
affect and the intercept of negative affect was not significantly
associated with the slope of pain.
Hypothesis 3: Pain and Alcohol Treatment Outcomes
Mediated by Negative Affect
The parallel process growth models of pain and negative affect
scores were extended to include covariates and 12-month drinking
outcomes with negative affect as a mediator of the association
between pain scores and drinking outcomes. All models provided
an adequate fit to the data based on RMSEA and CFI. Results from
the analyses were largely consistent across the COMBINE and
UKATT datasets, such that in all models the negative affect
growth factors (intercept and/or slope) significantly mediated the
association between pain and drinking outcomes, providing sup-
port for Hypothesis 3.
In COMBINE (see Table 4), when negative affect was included
in the model, the association between the pain growth factors in
predicting drinking outcomes (Hypothesis 1) was no longer sig-
nificant, and there were significant mediation effects of both the
negative affect intercept and the negative affect slope. Numerous
significant covariate effects were noted across all drinking out-
come models. Males and individuals with higher ADS scores had
significantly higher 12-month PDD and greater readiness to
change at baseline was associated with significantly lower 12-
month DDD and MXD. Across all four drinking outcomes, being
female, unmarried, non-Hispanic White, more severe dependence
severity (as measured by ADS and DSM–IV), and reporting lower
self-efficacy were significantly associated with higher negative
affect (intercept), and racial minority status predicted an increase
in negative affect over time (slope). Being married, unemployed,
with a lower income, and more severe dependence severity were
associated with greater pain (intercept). None of the covariates
were significantly associated with changes in pain over time.
In UKATT (see Table 5), the negative affect intercept did not
mediate the association between the pain intercept and DDD,
PHDD, or MXD outcomes. In other words, Hypothesis 3 was not
supported for the intercept of negative affect mediating the inter-
cept of pain in predicting PDD, PHDD, and MXD. On the con-
trary, Hypothesis 3 was supported for the intercept of negative
affect mediating the association between the pain intercept and
frequency of drinking (PDD). Hypothesis 3 was also supported for
the slope of negative affect. The negative affect slope (change in
negative affect over time) significantly mediated the association
between the pain slope (change in pain over time) and all four
drinking outcomes. As with COMBINE, we found several signif-
icant covariate effects. Males, individuals with higher LDQ scores,
those with lower readiness to change, and lower self-efficacy had
significantly higher 12-month PDD and PHD. Greater self-efficacy
at baseline and employment were also associated with significantly
lower 12-month DDD and MXD. Across all four drinking out-
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comes, being unemployed, with more severe dependence severity
(as measured by LDQ and DSM–IV), lower self-efficacy, and
opiate use were significantly associated with higher negative affect
(intercept) and being unemployed with greater dependence sever-
ity (measured by LDQ) predicted an increase in negative affect
over time (slope). Being unemployed, greater dependence severity
(measured by DSM–IV), lower self-efficacy, and opiate use were
associated with greater pain (intercept). Covariates were not sig-
nificantly associated with changes in pain (slope).
Effects of Treatment Assignment
Results from conditional latent growth curve models indicated
that none of the treatment contrasts in either COMBINE or
UKATT had a significant effect on the intercept or slope of pain
scores over time. Treatment condition also did not moderate the
associations between pain and drinking outcomes or associations
between pain and negative affect in COMBINE (all p  0.10).
In UKATT, treatment significantly moderated the association
between the pain intercept (end of treatment pain scores) and
percent heavy drinking days (PHDD) at the 12-month follow-up
(B (SE)  0.01 (0.004), p  .045). As shown in Figure 2, the
association between the pain intercept and 12-month PHDD was
significant for the MET condition (B (SE)  .14 (.04), p  .001),
but was nonsignificant for the SBNT condition (B (SE)  .007
(0.04), p  .87). Treatment also significantly moderated the asso-
ciation between the pain intercept and the negative affect intercept
(B (SE)  0.01(0.006), p  .028); however, the simple slope
analysis revealed that pain and negative affect were significantly
positively associated in both treatment conditions, with a stronger
association in MET (standardized 	  0.46), as compared to
SBNT (standardized 	  0.37).
Results from the moderated mediation analyses were also sig-
nificantly different by treatment condition in UKATT for the DDD
outcome. The mediating effect of the negative affect slope was
only significant in the association between pain slopes and DDD
for the MET condition (indirect effect B (SE)  0.002 (0.001),
95% CI: 0.001, 0.004), while the mediating effects were not
significant for the SBNT condition (indirect effect B (SE)  .002
(0.002), 95% CI: 0.001, 0.004). Treatment condition moderated
the effect of the “b-path” (i.e., negative affect slope in predicting
DDD), with the association between negative affect slope and
DDD significantly positive in the MET condition and nonsignifi-
Table 3
Results From Analyses of Pain Growth Factors Predicting 12-Month Drinking Outcomes
	 B (SE) R2
COMBINE
12-month Percent Drinking Days (PDD) 0.09
Baseline PDD 0.30 0.52 (0.05)
Pain interference intercept 0.06 0.04 (0.02)
Pain interference slope 0.001 0.01 (0.13)
12-month Drinks per Drinking Day (DDD) 0.07
Baseline DDD 0.22 0.17 (0.02)
Pain interference intercept 0.11 0.01 (0.003)
Pain interference slope 0.01 0.01 (0.02)
12-month Percent Heavy Drinking Days (PHDD) 0.06
Baseline PHDD 0.22 0.33 (0.05)
Pain interference intercept 0.08 0.05 (0.02)
Pain interference slope 0.001 0.006 (0.13)
12-month Maximum Drinks per Day (MXD) 0.05
Baseline MXD 0.18 0.10 (0.02)
Pain interference intercept 0.12 0.02 (0.004)
Pain interference slope 0.01 0.01 (0.03)
UKATT
12-month Percent Drinking Days (PDD) 0.10
Baseline PDD 0.25 0.40 (0.07)
Pain interference and intensity intercept 0.08 0.04 (0.02)
Pain interference and intensity slope 0.15 0.35 (0.50)
12-month Drinks per Drinking Day (DDD) 0.16
Baseline DDD 0.38 0.34 (0.01)
Pain interference and intensity intercept 0.09 0.02 (0.007)
Pain interference and intensity slope 0.11 0.09 (0.14)
12-month Percent Heavy Drinking Days (PHDD) 0.09
Baseline PHDD 0.25 0.38 (0.06)
Pain interference and intensity intercept 0.09 0.05 (0.02)
Pain interference and intensity slope 0.13 0.30 (0.44)
12-month Maximum Drinks per Day (MXD) 0.15
Baseline MXD 0.36 0.33 (0.04)
Pain interference and intensity intercept 0.10 0.02 (0.01)
Pain interference and intensity slope 0.11 0.13 (0.24)
Note. 	  standardized regression coefficient; B  unstandardized regression coefficient; SE  Standard
Error.
 p  .05.  p  .01.
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cant in the SBNT condition. Thus, the SBNT intervention attenu-
ated the mediating effect of negative affect on DDD in UKATT.
Discussion
The findings from current study suggest that pain and negative
affect are closely associated among individuals who received treat-
ment for AUD and that negative affect significantly mediated the
association between pain and drinking outcomes. This suggests
that negative affect-mediated pain may be an important risk factor
in the alcohol relapse process. These results support all three
hypotheses regarding the associations between pain, negative af-
fect, and drinking outcomes. Specifically, the level of pain at
the end of treatment (i.e., pain intercept) significantly predicted
drinking frequency and intensity at 12 months posttreatment
(COMBINE) and 9 months posttreatment (UKATT), supporting
the first hypothesis that pain and drinking outcomes would be
significantly associated. Interestingly, the slopes of the pain
growth factors were not significantly associated with drinking
outcomes, after controlling for baseline drinking outcomes and
pain intercepts. Thus, it may be most important to assess the level
of pain at the end of treatment and changes in pain following
treatment may be less predictive of ultimate drinking outcomes.
The results also indicated that pain and negative affect were
significantly associated (supporting Hypothesis 2) and that nega-
tive affect significantly mediated the association between pain and
drinking outcomes (supporting Hypothesis 3).
The finding that negative affect significantly mediated the as-
sociation between pain and drinking outcomes is consistent with a
growing literature on the importance of negative affect as a me-
diator of drinking outcomes (Allan, Albanese, Norr, Zvolensky, &
Schmidt, 2015; Black et al., 2012; Kelly, Hoeppner, Stout, &
Pagano, 2012). Targeting negative affect in the treatment of AUDs
has been described previously (Lowman, Allen, Stout, & The
Relapse Research Group, 1996; Witkiewitz & Villarroel, 2009),
and the current results would suggest that interventions to reduce
negative affect might be particularly important among individuals
with chronic pain. The results from the current study are also
consistent with a growing literature on the association between
pain and addiction treatment outcomes (Brennan, Schutte,
SooHoo, & Moos, 2011; Caldeiro et al., 2008; Sheu et al., 2008).
To our knowledge, this is the first study to examine the association
between pain and alcohol treatment outcomes as mediated by
negative affect. Moreover, the results were largely replicated
across two different randomized clinical trials conducted in two
Table 4
Results From Analyses of Pain Growth Factors Predicting 12-Month Drinking Outcomes
Mediated by Negative Affect in COMBINE
COMBINE B (SE; 95% CI) R2
12-month Percent Drinking Days (PDD) (RMSEA  .05 (90% CI: 0.04, 0.06), CFI  .98) .28
Baseline PDD 0.48 (0.04)
Pain interference intercept 0.02 (0.03)
Pain interference slope 0.71 (0.77)
Negative affect intercept 0.10 (0.02)
Negative affect slope 2.89 (1.50)
Pain intercept ¡ Affect intercept ¡ PDD Mediation .01 (.003; 95% CI: .01, .02)
Pain slope ¡ Affect slope ¡ PDD Mediation .97 (.71; 95% CI: 0.33, 3.23)
12-month Drinks/Drinking Day (DDD) (RMSEA  .05 (90% CI: 0.04, 0.06), CFI  .98) .23
Baseline DDD 0.14 (0.04)
Pain interference intercept 0.004 (0.004)
Pain interference slope 0.07 (0.12)
Negative affect intercept 0.02 (0.003)
Negative affect slope 0.40 (0.22)
Pain intercept ¡ Affect intercept ¡ DDD Mediation .003 (.001; 95% CI: .002, .004)
Pain slope ¡ Affect slope ¡ DDD Mediation .13 (.10; 95% CI: .04, .45)
12-month % Heavy Drinking Days (PHDD) (RMSEA  .05 (90% CI: 0.04, 0.06), CFI  .98) .28
Baseline PHDD 0.33 (0.04)
Pain interference intercept 0.02 (0.03)
Pain interference slope 0.69 (0.79)
Negative affect intercept 0.11 (0.02)
Negative affect slope 3.19 (1.56)
Pain intercept ¡ Affect intercept ¡ PHDD Mediation .02 (.003; 95% CI: .01, .02)
Pain slope ¡ Affect slope ¡ PHDD Mediation 1.07 (.76; 95% CI: .41, 3.43)
12-month Maximum Drinks/ Day (MXD) (RMSEA  .05 (90% CI: 0.04, 0.06), CFI  .98) .23
Baseline MXD 0.07 (0.04)
Pain interference intercept 0.007 (0.01)
Pain interference slope 0.11 (0.16)
Negative affect intercept 0.02 (0.004)
Negative affect slope 0.59 (0.28)
Pain intercept ¡ Affect intercept ¡ MXD Mediation .003 (.001; 95% CI: .002, .01)
Pain slope ¡ Affect slope ¡ MXD Mediation 0.20 (.14; 95% CI: 0.07, 0.64)
Note. B  unstandardized regression coefficient; SE  Standard Error; 95% CI  95% confidence interval of
mediated effect.
 p  .05.  p  .01.
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different countries (U.S. and U.K.) that included patients at very
different levels of physical health severity and disparate drinking
rates at baseline (as seen in Tables 1 and 2).
The differential findings by treatment conditions in UKATT, but
not COMBINE, were particularly intriguing and deserve further
exploration and replication. In UKATT, the associations between
pain and drinking outcomes, pain and negative affect, and the full
mediational model were moderated by treatment condition. The
SBNT condition attenuated the associations, such that greater pain
did not predict significantly greater PHDD and greater pain did not
predict as strong of an association with negative affect, as com-
pared to the MET condition. COMBINE included a comparison of
medications (naltrexone, acamprosate, or placebo) to one behav-
ioral intervention (CBI), whereas UKATT compared a lower in-
tensity behavioral intervention (MET) with a higher intensity
behavioral intervention (SBNT). Thus, it could be the intensity of
the behavioral intervention or the content of the SBNT interven-
tion was important for attenuating the associations between pain,
negative affect, and drinking outcomes. Given the fairly well-
established efficacy of behavioral interventions for persistent pain
(e.g., Ehde, Dillworth, & Turner, 2014; Gatchel, Peng, Peters,
Fuchs, & Turk, 2007), a possibility is that the SBNT helpfully
altered participants’ responses to their pain experiences, as well as
in relation to alcohol use.
SBNT also attenuated the association between changes in neg-
ative affect and DDD, suggesting that individuals who experienced
greater negative affect did not show corresponding increases in
DDD at the 12-month follow-up. Previous research has found
behavioral treatments for addiction, including cognitive–
behavioral treatment, may be partially effective by changing indi-
vidual responses to negative affect such that individuals tend not to
drink or use drugs in response to negative affect (Hunter, Witkie-
witz, Watkins, Paddock, & Hepner, 2012). The SBNT intervention
of UKATT utilized cognitive and behavioral strategies to build
social support networks that were supportive of reduced drinking
or abstinence and it is possible that increasing social support also
provided an avenue for attenuating the reaction of frequent heavy
drinking in response to both pain and negative affect. Numerous
studies have found social support networks to be important in the
recovery process following treatment for AUD (e.g., Havassy,
Hall, & Wasserman, 1991; Timko, Finney, & Moos, 2005; Walter
et al., 2006). Consistent with these correlational studies, a recent
experimental study found that social partners reduced alcohol
relapse-like behavior in prairie voles (Hostetler & Ryabinin,
Table 5
Results From Analyses of Pain Growth Factors Predicting 12-Month Drinking Outcomes
Mediated by Negative Affect in UKATT
UKATT B (SE; 95% CI) R2
12-month % Drinking Days (PDD) (RMSEA  .08 (90% CI: 0.06, 0.09), CFI  .96) .19
Baseline PDD 0.30 (0.07)
Pain interference and intensity intercept 0.09 (0.03)
Pain interference and intensity slope 0.03 (0.16)
Negative affect intercept 0.08 (0.04)
Negative affect slope 0.19 (0.04)
Pain intercept ¡ Affect intercept ¡ PDD Mediation .01 (.01; 95% CI: .03, .001)
Pain slope ¡ Affect slope ¡ PDD Mediation .008 (.002; 95% CI: .004, .012)
12-month Drinks/Drinking Day (DDD) (RMSEA  .08 (90% CI: 0.06, 0.09), CFI  .96) .29
Baseline DDD 0.28 (0.06)
Pain interference and intensity intercept 0.004 (0.01)
Pain interference and intensity slope 0.002 (0.05)
Negative affect intercept 0.02 (0.02)
Negative affect slope 0.06 (0.02)
Pain intercept ¡ Affect intercept ¡ DDD Mediation .004 (.003; 95% CI: .001, .01)
Pain slope ¡ Affect slope ¡ DDD Mediation .002 (.001; 95% CI: .001, .004)
12-month % Heavy Drinking Days (PHDD) (RMSEA  .08 (90% CI: 0.06, 0.09), CFI  .96) .23
Baseline PHDD 0.28 (0.07)
Pain interference and intensity intercept 0.07 (0.03)
Pain interference and intensity slope 0.01 (0.12)
Negative affect intercept 0.05 (0.04)
Negative affect slope 0.21 (0.04)
Pain intercept ¡ Affect intercept ¡ PHDD Mediation .009 (.01; 95% CI: .02, .004)
Pain slope ¡ Affect slope ¡ PHDD Mediation .009 (.002; 95% CI: .005, .01)
12-month Maximum Drinks/Day (MXD) (RMSEA  .08 (90% CI: 0.06, 0.09), CFI  .96) .27
Baseline MXD 0.30 (0.05)
Pain interference and intensity intercept 0.005 (0.01)
Pain interference and intensity slope 0.00 (0.07)
Negative affect intercept 0.03 (0.02)
Negative affect slope 0.07 (0.02)
Pain intercept ¡ Affect intercept ¡ MXD Mediation .01 (.004; 95% CI: .002, .01)
Pain slope ¡ Affect slope ¡ MXD Mediation .003 (.001; 95% CI: .001, .01)
Note. B  unstandardized regression coefficient; SE  Standard Error; 95% CI  95% confidence interval of
mediated effect.
 p  .05.  p  .01.
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2014). Research on chronic pain has also found social support to
predict better pain outcomes in correlational studies (Montoya,
Larbig, Braun, Preissl, & Birbaumer, 2004) and experimental
animal studies (Gabriel, Marcus, Honig, & Joosten, 2010; Vachon
et al., 2013). In addition, there is research to suggest that individ-
uals with chronic pain who indicate satisfaction with social support
show decreased levels of depressed mood and pain intensity
(López-Martínez, Esteve-Zarazaga, & Ramírez-Maestre, 2008) as
well as pain interference (Kerns, Rosenberg, & Otis, 2002). Future
research should be conducted to examine whether SBNT may be
an effective treatment for comorbid pain and AUD.
Strengths and Limitations
The strengths of the current study include the replication of
findings across two large datasets and the careful statistical ap-
proach to both datasets. Statistical procedures included the repli-
cation of longitudinal latent variable models to study the associa-
tions between constructs over time, while also controlling for
multiple covariates and handling missing data using maximum
likelihood estimation (Hallgren & Witkiewitz, 2013). The fact that
the two clinical trials represent different samples with regard to
severity and nationality is an additional strength. Further, the
findings were replicated using different measures of pain and
negative affect in each of the datasets.
The limitations include the lack of a measure of pain intensity in
COMBINE and the lack of a multidimensional pain measure in
either study. The COMBINE study assessed pain interference only
and UKATT assessed both pain intensity and interference. We
elected to combine these into a single latent factor, simply labeled
as pain in the present analyses, partially because the pattern of
findings across the two studies was similar and partially due to the
practical fact that no other measures were available to us. How-
ever, variability in responses to pain intensity and pain interference
may have influenced the pattern of results in some way, and future
studies in this area would benefit from more uniform and thorough
assessment of both pain intensity and interference. The use of
single measures for negative affect in each dataset is also a
limitation. Finally, the current study was limited by looking at
drinking outcomes only at a single follow-up time point (12
months posttreatment in COMBINE, 12 months postbaseline in
UKATT), rather than examining time-varying associations be-
tween pain, negative affect, and drinking outcomes.
Figure 2. Association between pain scores at the end of treatment and percent heavy drinking days by
treatment condition in UKATT. MET  Motivation enhancement therapy; SBNT  Social behavior and
network therapy.
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Conclusions and Future Directions
This study was the first to identify a longitudinal association
between indicators of pain, negative affect, and drinking outcomes
following AUD treatment. Chronic pain and AUD are both chronic
conditions that often require years of maintenance therapies. It is
critical to gain a better understanding of the association between
pain and AUD treatment outcomes, including potential mecha-
nisms of the association (e.g., negative affect). Studying the asso-
ciations between pain, negative affect, and AUD treatment out-
comes at self-report, behavioral, and neurobiological levels may
also be critical for the development of behavioral treatment options
for individuals with comorbid pain and AUD. The correlational
nature of the longitudinal panel data used in the current study
prevents any inferences regarding the directionality of the associ-
ations between pain, negative affect, and alcohol use; however,
future research employing ecological momentary assessment de-
sign could potentially disentangle temporal ordering of the asso-
ciations in real time.
The current study also holds numerous implications for inter-
vention research. Targeting negative affect in treatment might be
particularly useful among individuals with comorbid chronic pain
and AUD. There has been a growing focus on the utility of
mindfulness-based interventions in the treatment of chronic pain
and separately in the treatment of AUD and other substance use
disorders (Garland et al., 2014; Bowen et al., 2014), with some
studies finding that mindfulness-based interventions may be par-
ticularly beneficial for individuals with comorbid mood disorders
(Witkiewitz & Bowen, 2010; Zautra et al., 2008). Future treatment
research may also consider the findings from the current study
with regard to the attenuation of the pain–negative affect–drinking
associations via the social behavior and network therapy utilized in
UKATT.
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